An Observational Study to Learn More About How Safe Vericiguat is and How Well it Works in Indian People With Chronic Heart Failure With Reduced Ejection Fraction and Worsening Chronic Heart Failure Under Real World Conditions
Clinical trial NCT06632483 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06632483
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-08
- Primary completion
- 2026-06-30
- Enrollment
- 604
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.